Frost.com - Connected Health Research http://www.frost.com/c/10260/home.do http://www.frost.com/c/10260/home.do - Connected Health Research Frost & Sullivan eHealth Innovations in Western Europe http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297667379 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297667379 Healthcare in Western Europe is changing radically as a result of varying demographics, rise of chronic diseases, and mounting financial pressure on health systems to control overall healthcare expenditure. Tue, 20 Jun 2017 00:00:00 +0100 Global Healthcare Data Analytics Companies-To-Action, 2017 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K1E6-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K1E6-01-00-00-00 Healthcare data analytics refers to information technology (IT) solutions and services that mine structured and unstructured digital content generated by healthcare industry stakeholders with the goal of achieving a pre-defined outcome. The healthcare industry is experiencing a redefinition of value through the changing expectations of care quality, reimbursement models, and patient experience. To deliver new forms of value , industry stakeholders need a far more granular dissection of data and payers, providers, pharmaceuticals and medical technology companies are taking this move very seriously. To support these rapidly evolving stakeholders, data analytics vendors are bringing new and innovative solutions to the market that can help solve highly specific business issues around developing new solutions, revenue streams, operating models, and target customers. However, current solutions seem to have a rather niche scope, which creates obstacles for both data analytics companies rather complex and crowded market landscape consisting multiple solution segments and their healthcare industry customers. While data analytics vendors need to navigate a rather complex and crowded market landscape consisting of multiple solution segments, healthcare organizations need to invest in diverse vendors to meet their business goals. Future market success lies in providing meaningful analytics based on real-world data that accelerate R&D, enhance complete care pathways for specific therapeutic areas, and augment human thinking. Vendors need to expand their solutions across complete healthcare functions or therapeutic areas through appropriate partnerships and/or portfolio expansion. This creates opportunities for integration of different types of analytics solutions; integration of diverse healthcare stakeholders and datasets, and/or integration of diverse target market segments, such as providing solutions comprehensive platforms that support patients, providers, and payers. A complex vendor landscape creates opportunity for strategic partnerships amongst leading multinationals and small- and medium-sized businesses. At the same time, Industry Convergence opens up Blue Ocean markets where existing participants can provide new solutions, address evolving customer needs, and experiment with innovative business models. In such an environment, it becomes imperative for companies to have a clear view of the market landscape with a constant eye out for potential peers and competitors. Key parameters used for identifying appropriate industry partners include company size and growth, vision & goals, solution portfolio, market presence, and future plans. This research profiles vendors across diverse domains within Healthcare Data analytics to bring the most recent and successful and/or high-potential companies to light. Frost & Sullivan s focus has been to identify vendors who bring in the advantage purely in terms of analytics and not other components of data management and meaningful use. Key Questions this Study will Answer: What are the current growth opportunities in healthcare data analytics? What is the impact of the external industry environment on this market? Which are some unique companies that are introducing new and innovative solutions in the market? How do these companies intend to transform healthcare industry paradigms over the next five years? What is their action plan and potential for growth? What are some key success factors in the healthcare data analytics market? Tue, 13 Jun 2017 00:00:00 +0100 Internet of Medical Things, Forecast to 2021 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K1AB-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K1AB-01-00-00-00 Healthcare is one of the industries facing disruption by technological advances in the Internet of Things (IoT) space, and yet it is only partially aware of the advances, potential, and benefits. Almost 60% of healthcare organizations have already adopted healthcare IoT or Internet of Medical Things (IoMT), and realized cost savings, improved their profitability, visibility and customer experience. Indeed, IoMT serves the financial interests of healthcare industry stakeholders including investors, manufacturers, providers and physicians. It is well-suited to meet the needs of the transforming healthcare industry, by supporting the transition from disjointed care to coordinated care and reactive to proactive care-delivery approaches, for example. An estimated 4.5 billion IoMT devices existed in 2015, accounting for 30.3% of all IoT devices globally; this number is expected to grow to 20-30 billion IoMT devices by 2020. Capitalizing on this trend with the right applications for the right customers with the right partners and relevant business models is crucial for healthcare stakeholders to survive the fierce competition, which is supported by start-up companies and technology giants alike. With IoMT, a connected ecosystem of sensors and devices on and around the individual serve to capture and measure, identify, stratify risks, inform, make decisions and take actions. With that underlying principle, the IoMT market has five application areas. The On Body area covers wearable devices such as smart devices, peripherals, and even implants. The In Home environment includes digital/virtual assistants, activity monitors, and home medical devices. Within the Community segment, automated kiosks, emergency response intelligence and mobility are application areas. In the Clinic segment, handheld medical devices and care-coordination technologies as well as administrative support tools are areas where IoMT is making its mark. The In Hospital area benefits from IoMT use for real-time location services, patient/personnel flow tools and smart, connected equipment for better inventory management and resource utilization. This study covers the landscape of the Internet of Medical Things by application areas on body, in home, community, in clinic, and in hospital. For each application area, IoT use cases, vendor landscape of over 100 IoMT stakeholders, potential opportunities and challenges have been covered. Additionally, analysis on business model considerations for IoMT stakeholders, case studies, and future perspectives has also been provided. Key questions that this study will answer: What does the current IoMT market landscape look like? Which areas are being served, and by whom? What are the segment-specific challenges and opportunities for IoMT market incumbents and those considering entering the market? What strategies for success can be employed by stakeholders? What are the important business model considerations for IoMT stakeholders and new entrants? What are the future perspectives that IoMT industry stakeholders and new entrants should be aware of? Tue, 6 Jun 2017 00:00:00 +0100 Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MD05-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MD05-01-00-00-00 The cost of genomic sequencing has significantly declined in the recent past with the utilization of high-throughput sequencers creating opportunities for Next-generation Sequencing (NGS) informatics to develop genetic insights from the growing volume of sequencing data. As NGS technologies mature and the market stakeholders develop clarity on industry requirements, the market is expected to undergo significant transformation. Primary and secondary analyses are getting automated and commoditized with market growth being propelled by clinically focused tertiary analysis solutions. Support from government and R&D labs, launch of national-level genomic data collection initiatives, and expanding usage in the clinical space have provided impetus to the market in Europe. The NGS Informatics market has been segmented into 3 segments: secondary analysis, tertiary analysis and data storage. The European NGS Informatics market was worth $236.6 million in 2016 and is expected to reach $508.6 million by 2021 at a CAGR of 16.5%. Tertiary analysis represents the highest market share of 72%, followed by secondary analysis at 22% and data storage at 6%. The European NGS informatics is a competitive space with a handful global players and a large number of regional players vying for market share. Opportunities in NGS informatics market in Europe: As the industry matures, end users of NGS informatics services will look for focused and customized solutions. Customers expect seamless end-to-end genetic solutions in an easy-to-use format at competitive prices. Exacted NGS informatics is to be used for discovery and development in precision medicine, molecular diagnostics, and so on. Application of Big Data methodologies to handle the burgeoning genomic dataset and inclusion of novel data sources such as multi-omics and EMR/EHR data is expected. NGS informatics is likely to find application in novel areas such as agriculture/plant/animal biotechnology and in industries such as consumer products and food and nutrition. Europe is a key market in the global NGS informatics space with the presence of cutting-edge NGS technology infrastructure, a highly educated population receptive of NGS technologies and significant government support. UK, Germany, and France are likely to emerge as key markets. However, with a fragmented market and diverse regulatory and reimbursement rules across nations, NGS informatics companies are likely to face challenges in successful commercialization of their solutions. This study highlights the growing prominence of NGS informatics industry in Europe, growth opportunities, competitive dynamics, and a regional analysis of Europe. Key Questions this Study will Answer: 1. How is the market attractiveness for NGS service informatics over the years? 2. What are the factors driving the demand for NGS informatics? 3. Who will be the key users of NGS informatics in the future? 4. What will be the focal areas of application of informatics services? 5. What are the factors impacting informatics providers? 6. What are the key challenges being faced by stakeholders? 7. Which are the game-changing companies at work? 8. What are the strategic levers to stay on the growth trajectory? 9. How is the changing economic scenario affecting the regional market? 10. Which are the key markets in Europe? Wed, 31 May 2017 00:00:00 +0100 10 Ways Internet of Medical Things Is Revolutionizing Senior Care http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297607985 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297607985 In 2000 about 10% of the world s population were aged 60 or over. By 2015 that had risen to 12%. United Nations projections indicate that will have increased to 16% by 2030, and jumped to 22% by 2050. Fri, 26 May 2017 00:00:00 +0100 Recent Advances in Life Science Technologies http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-48-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-48-00-00 This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across different technologies, including genetic testing for cancer, exosome technology capabilities, and gene delivery approaches. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Cancer risk, genetic testing, gene delivery, telomerase reverse transcriptase, stem cell lines Fri, 26 May 2017 00:00:00 +0100 US Clinical Decision Support Systems Market, Forecast to 2021 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K163-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K163-01-00-00-00 Clinical Decision Support Systems and services have evolved from being an authoritative content market dominated by large Scientific, Medical, and Technical (STM) publishers to being a dynamic and evolving connected infrastructure that includes digital workflow, electronic health record (EHR), and a variety of point-of-care solutions. While clinical guidelines and protocols remain critical components of this market, the landscape now includes a mix of suppliers, including medical device manufacturers and cloud-based clinical surveillance tools. The overall CDSS market is expected to grow by a CAGR of 8.9% from 2016 to 2021. Point-of-care solutions will be a key area of market growth. EHR providers will strive to become the hub of a CDSS, either by integrating access to CDS sources from within the EHR or through links to sources that have partnering agreements with the EHR provider. Workflow solutions, such as Computerized Physician Order Entry Systems (CPOE), documentation and scheduling sources, in addition to charge capture capabilities are also important in the market. One exciting aspect of CDSS in the digital era is the growing volume of patient data derived from medical devices, and monitoring systems, both from within the hospital and remotely. Additional scores of data signal expanded opportunities for new data analytics systems and models. This growing cache of medical data should support breakthroughs in Population Health Management Systems. Perhaps, the most exciting segment within CDSS is clinical surveillance systems that are capable of spotting serious patient-related issues with even more reliability than expert medical staffers. These systems use advanced data models to spot, at the point-of-care, nuances among the complex mix of medical indicators that may signal the prelude for a serious-yet-preventable medical event. This report also covers an array of established and new industry participants offering services in the segments covered, such as Wolters Kluwer, Zynx Health, The American College of Radiology, athenahealth, Philips, Elsevier, HCA, Premier, IBM (Truven), Inovalon, eClinical Works, Epic, Meditech, Perigen, Isabel Health, Motive Medical Intelligence, and many others. Major questions this research will answer include: What are the major trends impacting the CDSS space? What are the major participants across CDSS and by market segment? What are the competitive dynamics of the CDSS market? What is the revenue outlook for CDSS and the major segments? What are the strategic imperatives and calls to action that will define growth and success within the CDSS market over the next five years? Frost & Sullivan predicts that CDSS will evolve to become advanced predictive analytic tools, based on input from a patient s history, next-generation sequencing, and patient-generated data. Complex machine learning algorithms, artificial intelligence, and cognitive computing will influence advances in CDSS over the coming decades. The report also predicts the growing importance for patients to have access to CDSS from reliable medical-grade sources. Thu, 18 May 2017 00:00:00 +0100 Top 9 Predictions for Global Healthcare 2017 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297564501 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297564501 Public and political pressure on controlling surging drug prices globally will compel health authorities to take transparency measures around drugs pricing, especially for some of the expensive diabetes and cholesterol medicines Thu, 4 May 2017 00:00:00 +0100 How All of Medicine will become Precision Medicine: 5 Evolving Trends to Watch http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297562372 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297562372 Precision medicine promises a paradigm shift in the care delivery arena. It is a new model of medicine with new disease taxonomy. In future, precision medicine will be enabled by data both from direct and indirect sources, probing the deepest mysteries affecting individual health and well-being. Wed, 3 May 2017 00:00:00 +0100 Why Digital Solutions Are Poised to Disrupt the Behavioral Healthcare Industry http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297557874 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297557874 The lack of mental health parity in care delivery has been spoken of several times before, but probably little has been done globally to treat this serious cause of disability. Tue, 2 May 2017 00:00:00 +0100 3D Printing Medical Devices http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297558858 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297558858 3D printing, a relatively new wave of manufacturing technology has made huge impact on healthcare industry globally by providing customization to a growing number of healthcare applications and bringing down the cost. Tue, 2 May 2017 00:00:00 +0100 End-user and Decision-maker Survey of Southeast Asian PACS Market, Forecast to 2021 http://www.frost.com/prod/servlet/sublib/display-report.do?id=P96D-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=P96D-01-00-00-00 The research service provides an in-depth analysis of the Picture Archiving and Communication System (PACS) market across six Southeast Asian countries with a focus on end-user and radiology decision-maker needs, challenges, and vendor preferences. The study provides opportunity analysis, vendor landscape, and evolving technology and business model trends between 2016 and 2021. Key Target Audience: The study is an excellent starting point for both multinational imaging informatics leaders as well as local vendors aiming to enter and expand penetration in Southeast Asia. The research service is also relevant for healthcare providers, as it highlights the key challenges faced by radiologists and emerging technologies that can help improve the efficiency and service quality of the radiology department. Research Scope: At a compound annual growth rate (CAGR) of 6.8% between 2016 and 2021, the Southeast Asian PACS market represents a rapidly maturing sector with revenue opportunities for both new and renewal solutions. The market stands divided between two distinct types of consumers: the experienced PACS decision makers and the novices. Organizations that are currently investing in their second or third generation of PACS are well aware of the workflow issues that may arise due to an under-planned implementation. These experienced PACS decision makers are turning toward vendor-neutral solutions and heavily emphasize the need for better interoperability in the radiology department. Furthermore, several hospitals, especially in the Philippines and Vietnam, will be investing in their first PACS solution and are thus, more budget conscious and also want to take baby steps toward digitalization. Indonesia and Malaysia are the fastest growing countries in the region, followed closely by Thailand. Singapore represents a progressive market that is ready for sophisticated solutions including advanced viewers, imaging analytics, and decision support tools. The study provides further insights into target hospital segments and ideal channels for market penetration across each of these countries. A key finding of the study is that many PACS end users and decision makers feel that vendors do not collaborate enough with hospitals while building the solution. Healthcare providers would like to work with vendors who truly understand individual hospital workflows and then design solutions. While not so much interested in modularity, providers would certainly want their imaging IT solutions to be scalable, keeping in mind the fast pace of hospital infrastructure and services expansion in the region. Southeast Asian countries covered in this study: Indonesia Malaysia The Philippines Singapore Thailand Vietnam Key Questions This Study Will Answer: What is the market opportunity for PACS in Southeast Asia? Which countries and hospital segments represent opportunity hotspots for PACS? What are the unmet needs of target hospital segments and what are some vendor strategies for addressing these needs? How are vendors driving market entry and penetration? How will technological advancement fuel market growth, especially business model innovation? How will the competitive landscape evolve over the next five years? Fri, 28 Apr 2017 00:00:00 +0100 Future of Bionics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7B1-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7B1-01-00-00-00 This Research Service (RS) offers a strategic perspective on the global emerging industry of bionics technologies. This research service is segmented into three chapters, with the first two focusing on analysis of the top trends from both technology and end-user perspectives. The third chapter brings out the competitive landscape, focusing on strategic scenarios within the industry, reviewing the roles and strategies of both existing and emerging participants in the global market. Key questions answered in this research service: 1. What is the role played by NPD (new product development) and research initiatives in improving the overall adoption of bionic technologies? 2. What are the ongoing shifts in the healthcare needs which are largely driving research and development of bionic prosthetics? 3. What are the potential technology-enabled business models that could be explored by existing competitors, and new players entering into the global industry for the bionic prosthetics? 4. Investments in bionic technologies are expected to increase. What are the strategic priorities of existing and new participants in developing the global market? Wed, 26 Apr 2017 00:00:00 +0100 Internet of Medical Things (IoMT) Revolutionizing Healthcare http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7B0-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7B0-01-00-00-00 As consumers take more responsibility of their own health and demand better access to their medical data, the process of extracting this data to provide meaningful insights needs an incremental change. In the next few years, advanced, connected and smarter patient monitoring devices will be available to consumers that will be able to gather real-time data including genetics and lifestyle behavior. This will help the IoMT market grow at a significant rate. Internet of Medical Things (IoMT) is an amalgamation of medical devices and applications that can connect to healthcare information technology (IT) systems using networking technologies. It connects patients to their physicians and allows transfer of medical data over a secure network, which in turn reduces unnecessary hospital visits and reduces the burden on healthcare systems largely. This research service evaluates the role played by networked devices and analytics in enabling digital healthcare transformation. Key questions answered in this study: 1. How internet of medical things (IoMT) differ from mobile healthcare technologies in improving the quality and reliability of healthcare infrastructure? 2. What is the role played by advanced computing techniques and analytics in secure storage, transmission and decoding of voluminous data over long distances by the use of IoMT? 3. How can IoMT enable clinicians to reliably use medical data in the process of making decisions for improving treatment for a variety disorders? 4. What is the role played by IoMT in securing critical clinical data from cyber and phishing attacks, preventing loss of medical data or leak of patient's medical history? Wed, 26 Apr 2017 00:00:00 +0100